These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical use of Ugarone capsules (urogastrone)]. Fujiwara M; Kawashima M Naika Hokan; 1968 Apr; 15(4):117-20. PubMed ID: 5693428 [No Abstract] [Full Text] [Related]
3. [Experience in the therapy of peptic ulcer with temequine and pyrilene]. Shubina LA Sov Med; 1968 Oct; 31(10):87-92. PubMed ID: 5744974 [No Abstract] [Full Text] [Related]
5. [Clinical use of sialogastrone in stomach diseases]. Irie K; Fujita K; Okuno T; Ijiri Y; Tosa M Horumon To Rinsho; 1969 Sep; 17(9):777-81. PubMed ID: 4243123 [No Abstract] [Full Text] [Related]
6. [The gastric anti-ulcer effects of urogastrone, mainly attributable to its paralytic action on the hypothalamic centers regulating gastric secretion and motility]. La Barre J Brux Med; 1974 Dec; 54(12):687-92. PubMed ID: 4434240 [No Abstract] [Full Text] [Related]
7. [On the mechanism of action and therapeutic effects of Urogastrone, an anti-ulcer hormone of pituitary origin]. La Barre J; Malfliet T Brux Med; 1967 Nov; 47(48):1133-42. PubMed ID: 5621591 [No Abstract] [Full Text] [Related]
9. [Combination of cholinolytics and insulin in the treatment of patients with peptic ulcer relapse]. Kushnir VE; Degtiareva II; Spivak AM; Liashko NA; Lapchinskiĭ ID Vrach Delo; 1983 Jul; (7):29-32. PubMed ID: 6353762 [No Abstract] [Full Text] [Related]
10. [Use of the alpha-adrenoblockader, fentolamin, in peptic ulcer of the duodenum]. Tsimmerman IaS; Lokhanin VA; Korshak AL; Groĭsman SD Vrach Delo; 1978 Jul; (7):70-3. PubMed ID: 356426 [No Abstract] [Full Text] [Related]
11. [Endoscopic and bioptic appraisal of the therapeutic effectiveness of Robuden in gastric pathology]. Mirelli E; Tritapepe R; Fichera G Minerva Gastroenterol; 1973; 19(2):87-115. PubMed ID: 4583475 [No Abstract] [Full Text] [Related]
12. [Gepharnate in the treatment of gastroduodenal ulcer]. Meeroff M Minerva Gastroenterol; 1972; 18(1):51-6. PubMed ID: 4614111 [No Abstract] [Full Text] [Related]
13. [Some indices of the functional state of the gastroduodenal system in peptic ulcer under various medical gymnastic procedures]. Mokrousova AT Vopr Kurortol Fizioter Lech Fiz Kult; 1973; 38(3):256-61. PubMed ID: 4747484 [No Abstract] [Full Text] [Related]
14. Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine. Camarri E; Zaccherotti L; D'Alonzo D Arzneimittelforschung; 1972 Apr; 22(4):768-72. PubMed ID: 5068258 [No Abstract] [Full Text] [Related]
15. Studies on the gastric secretion inhibitory substance in human saliva (Salivogastrone). II. Clinical study. Miyoshi A; Moriga M; Hirano S; Kobayashi M; Suyama T Naika Hokan; 1969 Aug; 16(8):319-34. PubMed ID: 4242609 [No Abstract] [Full Text] [Related]
16. [Use of sulpiride in gastroduodenal ulcer]. Capretti G; Guzzaloni A Minerva Gastroenterol; 1972; 18(4):241-4. PubMed ID: 4614120 [No Abstract] [Full Text] [Related]
17. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection]. Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873 [TBL] [Abstract][Full Text] [Related]
18. Peptic ulcer disease in the elderly. Cryer B; Feldman M Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250 [No Abstract] [Full Text] [Related]
19. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!]. Vallot T; Mignon M Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433 [No Abstract] [Full Text] [Related]
20. [Glucagon and its effect on the gastrointestinal tract]. Ratzmann KP; Knoke M Z Gesamte Inn Med; 1974 Feb; 29(3):94-7. PubMed ID: 4365192 [No Abstract] [Full Text] [Related] [Next] [New Search]